No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
684 |
4. Check minimum number of eventsNone |
684 |
5. Include endpointsNone |
684 |
6. Filter based on genotype QC (FinnGen only) |
638 |
Control definitions (FinnGen only)
- Control exclude
- L12_DERMATITISECZEMA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L30
- Name in latin
- Pompholyx
Similar endpoints
↥List of similar endpoints to
Dyshidrosis [pompholyx]
based on the number of shared cases.
Similar with more cases:
- Dermatitis
- Dermatitis and eczema
- Diseases of the skin and subcutaneous tissue
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3645 | 2184 | 1440 |
| Only index persons | 3395 | 2092 | 1303 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.04 |
| Only index persons | 0.07 | 0.08 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 39.06 | 39.22 | 38.77 |
| Only index persons | 38.66 | 38.88 | 38.32 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 638 | 449 | 189 |
| Unadjusted period prevalence (%) | 0.14 | 0.16 | 0.09 |
| Median age at first event (years) | 42.85 | 42.97 | 42.56 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 660
- Matched controls
- 6600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
XQ802
NOMESCO Finland
Epicutan test
153.3
307.7
243
25
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
23.8
307.7
284
203
L30.1
ICD-10 Finland
Dyshidrosis [pompholyx]
9428.9
307.7
604
8
XQ800
NOMESCO Finland
Prick test
17.5
224.2
210
171
L20.0
ICD-10 Finland
Besnier prurigo
+∞
221.7
200
*
D07AC13
ATC
mometasone; topical
10.8
212.7
427
961
D07AD01
ATC
clobetasol; topical
10.7
200.3
302
483
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
+∞
183.1
167
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
9.4
181.8
311
570
L30.3
ICD-10 Finland
Infective dermatitis
37.4
168.3
107
34
D07AC01
ATC
betamethasone; topical
8.4
163.1
446
1308
E0000UV, ,
ATC
8.7
154.4
491
1646
D07BC01
ATC
betamethasone and antiseptics; topical
8.9
130.4
195
296
E000001, ,
ATC
5.8
99.7
253
641
D02AE01
ATC
carbamide; topical
10.5
91.4
109
122
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
6.2
85.7
180
379
L30.0
ICD-10 Finland
Nummular dermatitis
14.8
73.5
68
51
TQW80
NOMESCO Finland
Local dermatologic skincare
21.3
72.0
55
28
L30.8
ICD-10 Finland
Other specified dermatitis
15.8
65.5
58
40
D07CC01
ATC
betamethasone and antibiotics; topical
5.0
61.6
159
394
D07AB02
ATC
hydrocortisone butyrate; topical
3.8
61.4
285
1089
D07AB08
ATC
desonide; topical
5.9
60.9
124
249
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
+∞
60.3
57
*
69283
ICD-8 Finland
Other eczema and dermatitis, Dysidroticum (pompholyx)
+∞
58.2
55
*
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
+∞
57.1
54
*
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
306.6
56.1
56
*
L20
ICD-10 Finland
Atopic dermatitis
+∞
50.7
48
*
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
17.7
48.3
40
24
D07CB01
ATC
triamcinolone and antibiotics; topical
12.5
47.7
48
41
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
490.9
46.9
46
*
D11AH01
ATC
tacrolimus; topical
479.4
45.8
45
*
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
5.4
45.5
98
205
H02AB06
ATC
prednisolone; systemic
3.0
41.0
375
2028
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
3.3
40.6
204
788
E000002, ,
ATC
4.3
39.2
114
304
D02AX
ATC
Other emollients and protectives
10.6
37.5
42
42
H02AB04
ATC
methylprednisolone; systemic
3.5
34.3
138
460
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
5.4
33.9
71
144
S87
ICPC
Dermatitis/atopic eczema
9.8
32.1
38
41
E000004, ,
ATC
11.2
30.7
33
31
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.2
30.5
142
516
D07XC01
ATC
betamethasone; topical
3.7
29.8
104
314
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
+∞
29.4
28
*
R06AE07
ATC
cetirizine; oral
2.5
28.6
358
2135
E000007, ,
ATC
5.3
27.8
58
117
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.4
24.6
66
164
R06AE09
ATC
levocetirizine; oral
2.8
23.5
138
565
L25.9
ICD-10 Finland
Unspecified contact dermatitis, unspecified cause
48.6
23.5
28
6
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
5.4
23.4
48
95
L24.0
ICD-10 Finland
Irritant contact dermatitis due to detergents
227.2
21.7
22
*
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
4.9
21.6
49
106
D09AB01
ATC
zinc bandage without supplements; topical
27.5
21.5
29
11
R06AX27
ATC
desloratadine; oral
2.2
21.3
258
1467
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
+∞
20.9
20
*
SPAT1263
SPAT
Sampling
2.2
20.6
317
1977
E000003, ,
ATC
5.1
20.2
44
92
R06AX22
ATC
ebastine; oral
2.5
19.9
152
705
WQ021, ,
NOMESCO Finland
+∞
19.9
19
*
J01DB01
ATC
cefalexin; oral
3.0
19.9
583
4710
A46
ICD-10 Finland
Erysipelas
2.9
19.8
102
387
D07XB05
ATC
dexamethasone; topical
6.5
19.4
32
51
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
5.5
19.4
38
72
B35.3
ICD-10 Finland
Tinea pedis
4.3
19.1
51
126
L04AX03
ATC
methotrexate; systemic
3.0
18.4
92
343
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
5.5
18.2
36
69
D07BA04
ATC
hydrocortisone and antiseptics; topical
3.2
18.1
79
272
S88
ICPC
Dermatitis contact/allergic
6.7
18.1
29
45
WQ007, ,
NOMESCO Finland
+∞
17.8
17
*
H02AB07
ATC
prednisone; oral
2.8
17.2
97
385
D05BB02
ATC
acitretin; oral
7.2
16.6
25
36
L23.1
ICD-10 Finland
Allergic contact dermatitis due to adhesives
92.5
16.6
18
*
L23
ICD-10 Finland
Allergic contact dermatitis
23.8
16.5
23
10
H25.8
ICD-10 Finland
Other senile cataract
3.5
16.1
58
177
N05BB01
ATC
hydroxyzine; systemic
3.5
16.1
57
172
J01AA04
ATC
lymecycline; systemic
2.4
16.1
124
573
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.7
16.1
92
368
N03AX16
ATC
[U] pregabalin
2.2
16.0
158
812
T78.4
ICD-10 Finland
Allergy, unspecified
3.9
16.0
48
129
SPAT1310
SPAT
Counselling related to known health issue
2.0
15.7
236
1423
L04AD01
ATC
ciclosporin; systemic
6.9
15.4
24
36
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.3
15.4
41
101
E000006, ,
ATC
3.7
15.0
49
140
UJF30
NOMESCO Finland
Ileoscopy through colon
2.7
14.8
85
340
L24.8
ICD-10 Finland
Irritant contact dermatitis due to other agents
153.3
14.5
15
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
14.5
140
712
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
27.9
14.3
19
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
14.3
288
1906
D07AA02
ATC
hydrocortisone; topical
2.5
14.0
102
458
S76
ICPC
Skin infection other
3.4
14.0
51
157
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
18.0
13.9
21
12
WQ020, ,
NOMESCO Finland
+∞
13.6
13
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
13.0
309
2137
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
12.7
175
1012
R03AC02
ATC
salbutamol; inhalant
1.8
12.6
390
2914
69282
ICD-8 Finland
Other eczema and dermatitis, E microbis
+∞
12.5
12
*
D11AX14
ATC
[U] tacrolimus
+∞
12.5
12
*
L20.8
ICD-10 Finland
Other atopic dermatitis
+∞
12.5
12
*
R01AD08
ATC
fluticasone; nasal
1.9
12.5
218
1364
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
12.5
93
421
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
132.4
12.5
13
*
J01MA12
ATC
levofloxacin; systemic
2.2
12.5
115
571
J01DA01
ATC
[U] cefalexin
1.8
12.4
411
3128
A02BC02
ATC
pantoprazole; systemic
1.8
12.4
430
3319
Z01.2
ICD-10 Finland
Dental examination
1.8
12.1
352
2567
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
27.3
12.1
16
6
OAB44, ,
SPAT
2.3
12.1
101
481
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.2
12.0
25
50
XG410
NOMESCO Finland
Flow-volume spirometry
4.1
11.9
33
84
L40.0
ICD-10 Finland
Psoriasis vulgaris
4.1
11.9
33
84
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.3
11.8
95
445
S29
ICPC
Skin symptom/complaint other
2.0
11.4
143
796
R01AD09
ATC
mometasone; nasal
1.8
11.3
332
2412
G47.3
ICD-10 Finland
Sleep apnoea
1.9
11.1
158
919
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.3
11.1
90
423
Z04.3
ICD-10 Finland
Examination and observation following other accident
4.6
11.0
26
58
R03BA05
ATC
fluticasone; inhalant
2.0
11.0
135
745
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
14.2
11.0
18
13
D07AC14
ATC
methylprednisolone aceponate; topical
3.6
11.0
36
103
L03
ICPC
Low back symptom/complaint
1.8
10.9
215
1386
J01FF01
ATC
clindamycin; systemic
1.9
10.9
177
1074
N02BF02
ATC
pregabalin; oral
2.8
10.8
55
206
J01DA09
ATC
[U] cefadroxil
1.9
10.8
186
1150
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
10.7
143
813
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
10.5
375
2854
B86
ICD-10 Finland
Scabies
3.7
10.5
33
92
N02AX02
ATC
tramadol; systemic, rectal
1.7
10.5
261
1800
L28.0
ICD-10 Finland
Lichen simplex chronicus
111.7
10.4
11
*
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
19.1
10.3
15
8
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
10.2
43
145
SPAT1216
SPAT
Assessment of functional ability
2.3
10.1
85
405
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.3
10.0
39
125
L12
ICPC
Hand/finger symptom/complaint
1.9
10.0
136
776
Z2221
NOMESCO Finland
Medical doctor
0.4
9.9
52
1177
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
9.9
283
2017
L01
ICPC
Neck symptom/complaint
2.0
9.9
128
719
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.9
9.9
47
170
CS494
NOMESCO Finland
Other visual field testing
4.8
9.8
22
47
M03BX02
ATC
tizanidine; oral
1.7
9.8
423
3364
L24.9
ICD-10 Finland
Irritant contact dermatitis, unspecified cause
55.8
9.7
11
*
M01AE02
ATC
naproxen; oral, rectal
1.7
9.7
400
3140
SPAT1312
SPAT
General health counselling
1.7
9.7
222
1489
L13
ICPC
Hip symptom/complaint
2.0
9.6
120
664
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
9.6
126
710
SPAT1311
SPAT
Counselling and guidance related to occupational health
3.3
9.6
36
113
L27.2
ICD-10 Finland
Dermatitis due to ingested food
101.4
9.4
10
*
L50.8
ICD-10 Finland
Other urticaria
5.3
9.4
19
37
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
+∞
9.4
9
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
9.2
175
1110
J20
ICD-10 Finland
Acute bronchitis
2.2
9.1
81
394
XQ848
NOMESCO Finland
Dermatological photography
4.9
9.1
20
42
J01AA02
ATC
doxycycline; systemic
1.8
9.1
483
4021
K05.31
ICD-10 Finland
Periodontitis pronounced
2.2
9.1
77
368
L08.0
ICD-10 Finland
Pyoderma
15.9
9.1
14
9
S21
ICPC
Skin texture symptom/complaint
2.0
9.0
104
559
D82
ICPC
Teeth/gum disease
1.7
9.0
288
2102
SPAT1283
SPAT
Restricted health certificate
1.8
8.9
158
979
Z00.0
ICD-10 Finland
General medical examination
1.9
8.6
133
789
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
8.6
42
154
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
27.9
8.5
11
*
L21.0
ICD-10 Finland
Seborrhoea capitis
20.3
8.5
12
6
E0001A1, ,
ATC
4.0
8.5
24
62
L50.0
ICD-10 Finland
Allergic urticaria
4.0
8.5
24
62
D11AH04
ATC
alitretinoin; oral
91.2
8.4
9
*
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
4.7
8.4
19
41
D11AH02
ATC
pimecrolimus; topical
+∞
8.3
8
*
69299
ICD-8 Finland
Other eczema and dermatitis, Due to other and unspecified cause
+∞
8.3
8
*
SPAT1322
SPAT
Pre-employment physical examination
3.9
8.3
24
63
S06
ICPC
Rash localized
2.8
8.3
43
163
R06AX18
ATC
acrivastine; oral
3.8
8.2
25
68
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
6.6
8.2
20
31
J37.0
ICD-10 Finland
Chronic laryngitis
3.2
8.2
32
103
J02AC02
ATC
itraconazole; systemic
1.9
8.2
116
669
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.2
8.2
70
336
DFF59
NOMESCO Finland
Other assessment of balance
10.2
8.1
15
15
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.8
8.1
41
154
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
8.0
67
318
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
8.0
187
1249
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
7.4
8.0
18
25
D05AX52
ATC
calcipotriol, combinations; topical
2.9
8.0
37
132
M54.5
ICD-10 Finland
Low back pain
1.6
8.0
252
1819
L16
ICPC
Ankle symptom/complaint
2.0
7.9
91
489
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
7.9
86
453
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
3.9
7.9
23
61
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
7.9
195
1323
C01CA24
ATC
epinephrine; parenteral
2.4
7.8
55
242
EB1VA, ,
NOMESCO Finland
1.8
7.8
136
836
PA7BD
NOMESCO Finland
CT angiography of neck and brain
7.6
7.7
17
23
D01BA02
ATC
terbinafine; oral
1.7
7.6
147
930
WYA00, ,
SPAT
4.2
7.6
20
49
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.3
7.5
60
279
N02BE01
ATC
paracetamol; systemic, rectal
2.0
7.4
580
5197
XQ899
NOMESCO Finland
Other assessment of skin
13.6
7.4
12
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.4
248
1809
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
7.4
128
785
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.2
7.3
28
89
D05AX02
ATC
calcipotriol; topical
3.6
7.3
24
69
J01FA10
ATC
azithromycin; systemic
1.6
7.2
405
3315
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
7.2
97
549
R06.0
ICD-10 Finland
Dyspnoea
1.7
7.2
154
1001
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
7.2
156
1018
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.2
7.2
65
319
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
3.4
7.2
25
75
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
7.2
72
368
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
8.1
7.1
15
19
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
7.1
71
362
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.6
7.1
41
165
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
7.1
139
883
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.7
7.0
170
1142
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.5
7.0
43
178
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
7.0
183
1254
SPAT1260
SPAT
Consultation of another employee
1.8
7.0
106
624
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.7
6.9
161
1069
R06AX13
ATC
loratadine; oral
1.8
6.9
110
657
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.1
6.9
65
324
M25.5
ICD-10 Finland
Pain in joint
1.6
6.8
227
1645
R01AD58
ATC
fluticasone, combinations; nasal
1.6
6.8
188
1303
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.4
6.8
47
206
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
6.8
390
3190
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
6.7
80
434
N07BA03
ATC
varenicline; oral
2.5
6.7
41
169
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
6.7
142
920
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.5
6.6
42
177
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.4
6.6
45
196
SPAT1229
SPAT
Assessment of need for aid
2.7
6.6
35
135
SPAT1254
SPAT
Administration of medicine
1.9
6.6
87
490
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
3.1
6.5
26
85
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.6
6.5
180
1246
Z51.6
ICD-10 Finland
Desensitization to allergens
6.3
6.5
16
26
L71.8
ICD-10 Finland
Other rosacea
5.8
6.5
17
30
SPAT1153
SPAT
Removal of sutures
1.6
6.5
172
1179
M79.1
ICD-10 Finland
Myalgia
1.8
6.4
111
678
395
Kela drug reimbursment
Dupilumab
70.5
6.4
7
*
M79.6
ICD-10 Finland
Pain in limb
1.5
6.4
277
2123
OAA63, ,
SPAT
8.3
6.4
13
16
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
6.0
6.3
16
27
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.3
6.3
23
71
R4110, ,
SPAT
1.9
6.3
85
481
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
6.3
229
1689
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.1
6.3
60
301
M23.8
ICD-10 Finland
Other internal derangements of knee
2.8
6.3
31
115
WQ055, ,
NOMESCO Finland
+∞
6.3
6
*
L25.8
ICD-10 Finland
Unspecified contact dermatitis due to other agents
+∞
6.3
6
*
L17
ICPC
Foot/toe symptom/complaint
1.6
6.3
193
1370
L11
ICPC
Wrist symptom/complaint
2.0
6.3
74
401
M75
ICD-10 Finland
Shoulder lesions
2.6
6.2
35
139
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.0
6.2
65
338
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
6.1
87
502
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
6.1
66
347
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
6.1
85
487
C03CA01
ATC
furosemide; systemic
1.7
6.1
112
697
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
273
629
6.70
122.18
4.4
4.1
30.88
31.37
%
0.29
204
427
186
409
5.94
84.45
1.3
1.2
298.99
156.98
u/ml
1.77
177
378
90
170
5.97
46.73
2.1
1.9
—
—
—
0
0
82
158
5.78
41.56
2.0
1.8
—
—
—
0
0
40
48
8.81
31.16
1.7
2.1
19.01
21.60
mg/l
—
8
24
49
79
6.62
29.56
1.6
1.3
—
—
—
0
0
49
79
6.62
29.56
1.6
1.3
—
—
—
0
0
49
79
6.62
29.56
1.6
1.3
—
—
—
0
0
48
76
6.73
29.45
1.6
1.3
—
—
—
0
0
48
76
6.73
29.45
1.6
1.3
—
—
—
0
0
47
75
6.67
28.62
1.6
1.3
—
—
—
0
0
89
258
3.83
26.93
3.8
2.9
0.75
1.61
mmol/l
0.94
66
182
100
314
3.57
26.90
4.1
2.9
5.16
5.13
kpa
0.18
94
306
71
176
4.40
26.56
1.2
1.1
3.58
7.65
eliau/ml
—
6
33
249
1345
2.37
23.78
2.5
2.1
—
—
—
0
0
30
43
7.26
20.08
1.4
1.3
—
—
—
0
0
56
149
4.01
18.98
1.2
1.2
2.71
3.03
u/ml
—
7
15
56
150
3.99
18.81
1.2
1.2
6.67
9.23
u/ml
—
9
26
256
1547
2.07
17.31
1.4
1.3
1.18
2.08
u/ml
0.96
45
440
530
4189
2.35
17.11
4.4
3.2
52.71
42.78
u/l
0.86
497
4005
412
5110
0.48
16.96
16.5
15.7
332.32
332.83
g/l
0.51
412
5082
49
134
3.87
15.98
1.3
1.4
26.17
18.81
u/l
0.78
39
111
142
707
2.28
15.51
1.7
1.7
818.65
1166.79
nmol/l
6.40
100
541
432
3248
1.96
14.61
9.6
9.1
4.07
4.02
e9/l
0.20
404
2841
23
15
15.83
14.49
1.7
1.1
8.76
7.87
ug/l
0.41
23
15
117
556
2.34
14.16
4.0
5.3
—
—
—
0
0
518
4181
2.11
13.92
5.1
4.0
10.60
10.01
mm/h
0.54
481
3943
52
170
3.23
12.95
1.8
1.2
—
—
—
0
0
259
1698
1.86
12.91
3.4
2.5
54.82
59.63
u/l
0.61
238
1575
275
1859
1.82
12.26
3.5
3.1
38.99
64.33
ng/l
0.28
164
1113
60
222
2.87
12.08
1.7
1.7
8.92
6.63
iu/ml
0.20
11
47
23
23
10.32
12.07
1.0
1.0
12.08
9.13
u/ml
0.27
16
18
17
8
21.76
12.06
1.5
1.0
—
—
—
0
0
316
2240
1.79
11.92
2.2
1.9
104.81
98.22
pmol/l
1.33
189
1201
216
1385
1.83
11.25
2.2
2.1
2.71
2.67
mg/l
0.09
177
1190
507
4197
1.90
10.80
8.8
7.5
80.96
76.10
u/l
1.16
485
3987
207
1337
1.80
10.38
1.6
1.5
2.47
2.28
g/l
0.51
123
850
308
2228
1.72
10.36
6.1
5.7
1.22
1.21
mmol/l
1.55
265
2055
25
57
4.52
10.34
1.1
1.1
—
—
—
0
0
336
2513
1.69
9.80
7.6
6.5
1.22
1.21
mmol/l
1.65
291
2171
365
2794
1.69
9.71
6.7
6.1
9.82
10.87
umol/l
1.08
341
2649
79
380
2.23
9.16
1.3
1.5
—
—
—
0
0
131
765
1.89
8.94
2.0
1.9
—
—
—
0
0
34
112
3.15
8.39
1.6
1.5
374.08
350.35
mu/l
0.09
26
89
50
213
2.46
7.65
1.3
1.7
14.59
7.70
u/ml
—
8
48
601
5445
2.16
7.58
6.5
5.2
1.73
1.82
mu/l
1.66
550
5135
37
137
2.80
7.47
2.8
2.8
—
—
—
0
0
219
1553
1.61
7.31
2.2
2.1
182.66
204.69
u/l
0.13
212
1481
77
402
2.04
7.22
2.2
2.4
10.17
18.46
au/ml
—
10
41
139
879
1.74
7.18
2.5
2.4
240.45
111.09
ug/g
0.99
103
700
389
3173
1.55
6.89
4.4
4.2
6.39
6.47
mmol/l
0.44
359
2941
17
41
4.23
6.58
1.6
2.4
—
—
—
0
0
164
1111
1.63
6.48
1.4
1.3
10.15
11.07
u/ml
0.06
50
453
199
1414
1.58
6.45
1.8
1.6
19.51
20.05
nmol/l
0.21
158
1206
18
47
3.91
6.29
1.6
2.2
—
—
—
0
0
591
5406
1.89
5.98
5.6
4.4
5.82
5.79
mmol/l
0.22
531
5044
177
1244
1.58
5.95
3.0
3.0
1333.08
829.45
ng/l
0.48
132
1023
16
31
5.26
5.73
2.0
1.4
—
—
—
0
0
170
1198
1.56
5.61
1.5
1.3
22.13
27.01
iu/ml
0.32
48
354
324
2613
1.47
5.58
2.7
2.5
75.83
74.74
nmol/l
0.27
287
2406
78
447
1.84
5.57
2.2
2.4
0.21
0.22
g/l
0.35
72
427
89
1403
0.58
5.50
3.2
2.8
0.19
0.39
e6/l
1.30
60
982
585
5363
1.80
5.47
4.9
3.8
1.36
1.25
mmol/l
2.33
524
5041
204
1507
1.51
5.40
1.8
1.7
—
—
—
0
0
125
827
1.63
5.35
1.7
1.8
1.50
1.42
%
0.57
106
751
13
22
6.00
5.24
1.8
2.1
—
—
—
0
0
13
22
6.00
5.24
1.8
2.1
—
—
—
0
0
13
22
6.00
5.24
1.8
2.1
—
—
—
0
0
13
22
6.00
5.24
1.8
2.1
—
—
—
0
0
28
110
2.61
5.11
1.1
1.1
2.31
2.02
eliau/ml
0.13
14
53
523
4683
1.56
5.09
5.1
4.3
14.57
14.49
pmol/l
0.36
476
4346
29
120
2.48
4.78
1.1
1.0
3.94
2.40
u/ml
0.36
16
50
570
5239
1.65
4.63
6.8
5.4
38.16
38.14
mmol/mol
0.02
522
4973
9
11
8.28
4.57
1.1
1.0
—
—
—
0
0
613
5753
1.92
4.57
16.3
12.4
21.71
21.52
mg/l
0.05
530
4616
6
239
0.24
4.43
2.7
1.4
—
—
—
0
0
26
107
2.49
4.35
1.0
1.0
0.30
0.06
u/ml
—
10
26
88
562
1.65
4.31
1.9
1.9
377.51
377.82
nmol/l
0.01
77
527
179
1340
1.46
4.30
2.6
2.6
332.31
328.38
umol/l
0.20
149
1207
32
149
2.21
4.09
1.6
1.3
199.50
322.99
ug/g
2.32
16
85
30
136
2.26
4.08
1.1
1.1
0.72
0.99
u/ml
0.30
17
60
635
6061
2.26
4.07
20.2
15.4
73.72
71.97
umol/l
0.77
625
5998
12
26
4.68
4.07
2.3
1.2
—
—
—
0
0
12
26
4.68
4.07
2.3
1.2
—
—
—
0
0
153
1124
1.47
4.02
3.2
2.1
—
—
—
0
0
604
5680
1.75
3.94
5.5
4.5
4.73
4.73
mmol/l
0.03
552
5396
55
316
1.81
3.93
2.3
1.6
—
—
—
0
0
634
6056
2.19
3.91
14.4
10.5
27.31
26.25
u/l
0.96
614
5918
47
808
0.55
3.89
3.0
2.6
1.73
3.01
e6/l
0.87
18
373
6
220
0.27
3.84
1.7
1.5
37.50
57.40
ug/l
—
6
220
20
77
2.65
3.84
1.3
1.2
—
—
—
0
0
8
254
0.31
3.78
1.8
1.7
—
—
—
0
0
7
8
8.83
3.78
1.1
1.0
—
—
—
0
0
198
1546
1.40
3.70
4.6
4.2
8.66
8.63
mg/mmol
0.00
118
960
10
20
5.06
3.70
1.7
1.8
—
—
—
0
0
20
79
2.58
3.66
1.3
1.2
—
132.00
—
0
5
12
30
4.05
3.61
2.3
1.2
—
—
—
0
0
12
30
4.05
3.61
2.3
1.2
—
—
—
0
0
13
35
3.77
3.61
1.8
1.9
—
—
—
0
0
13
35
3.77
3.61
1.8
1.9
—
—
—
0
0
13
35
3.77
3.61
1.8
1.9
—
—
—
0
0
41
221
1.91
3.58
1.7
1.6
—
—
—
0
0
53
861
0.58
3.57
2.8
2.4
0.55
0.93
e6/l
1.11
24
427
223
1786
1.38
3.56
3.8
3.3
7.75
8.11
mmol/l
0.49
168
1540
12
31
3.92
3.50
1.1
1.1
1249.50
1356.35
miu/ml
0.16
12
31
6
6
10.08
3.50
1.2
1.8
—
—
—
0
0
6
6
10.08
3.50
1.2
1.5
—
—
—
0
0
600
5661
1.66
3.49
5.5
4.5
1.44
1.48
mmol/l
2.04
547
5355
322
2740
1.34
3.44
2.6
2.7
—
—
estimate
—
0
0
605
5731
1.67
3.32
5.6
5.0
2.81
2.81
mmol/l
0.03
553
5427
28
535
0.50
3.27
2.4
1.8
—
—
—
0
0
262
2176
1.34
3.24
4.8
4.8
36.24
36.58
g/l
0.40
232
2062
65
415
1.63
3.22
2.7
2.1
1326.51
5373.02
u/l
1.82
25
186
585
5507
1.55
3.19
13.5
11.6
89.26
88.68
ml/min/173m2
0.26
537
5006
601
5693
1.62
3.18
16.7
13.6
139.56
139.70
mmol/l
0.67
585
5584
157
1210
1.39
3.12
3.2
2.3
—
—
—
0
0
358
3122
1.32
3.11
3.3
3.1
153.83
97.67
ug/l
0.73
323
2959
11
30
3.71
3.09
8.4
2.6
776.45
536.13
e6/l
0.59
11
24
6
8
7.56
3.06
1.2
1.0
—
—
—
0
0
10
281
0.35
3.05
1.6
1.6
—
—
—
0
0
8
17
4.75
2.92
1.9
2.3
—
—
—
0
0
8
17
4.75
2.92
1.9
2.3
—
—
—
0
0
8
17
4.75
2.92
1.9
2.3
—
—
—
0
0
7
13
5.43
2.87
1.3
1.4
—
—
—
0
0
21
96
2.23
2.86
1.2
1.1
28.13
210.83
iu/ml
—
8
23
14
53
2.68
2.81
1.1
1.1
—
—
—
0
0
7
14
5.04
2.73
1.0
1.4
—
—
—
0
0
114
851
1.41
2.71
2.4
2.4
14.97
14.10
umol/l
0.58
106
781
599
5702
1.55
2.71
17.1
13.7
3.96
3.93
mmol/l
1.27
583
5581
6
10
6.04
2.70
1.0
1.2
—
—
—
0
0
49
306
1.65
2.67
1.8
2.2
4.50
7.60
ug/l
1.11
38
274
41
244
1.73
2.67
1.7
1.6
—
—
—
0
0
31
170
1.86
2.63
1.1
1.1
2.78
2.84
u/ml
0.01
16
86
60
397
1.56
2.59
2.5
3.8
4.49
4.65
pmol/l
0.55
51
357
25
128
1.99
2.58
1.0
1.3
—
—
—
0
0
107
1399
0.72
2.51
2.6
3.4
1.02
1.02
kg/l
0.76
72
923
7
16
4.41
2.48
1.0
2.6
39.09
42.32
g/l
—
7
16
13
51
2.58
2.45
1.3
1.2
—
—
—
0
0
105
789
1.39
2.41
2.3
2.4
2.38
2.36
g/l
0.06
98
722
470
4328
1.30
2.39
3.4
3.5
—
—
—
0
0
13
52
2.53
2.37
1.3
1.3
—
—
—
0
0
6
13
4.65
2.27
1.2
1.2
—
—
—
0
0
6
13
4.65
2.27
1.2
1.2
—
—
—
0
0
29
487
0.58
2.25
3.3
2.9
—
—
—
0
0
72
512
1.46
2.24
5.5
4.2
230.93
257.69
u/l
0.47
67
488
5
9
5.59
2.21
1.0
1.0
—
—
—
0
0
100
1295
0.73
2.19
1.7
1.5
—
—
—
0
0
55
374
1.51
2.14
3.5
3.8
69.58
75.18
ng/l
0.27
48
329
22
117
1.91
2.08
1.3
1.6
7922.75
13156.60
e6/l
0.37
16
91
55
377
1.50
2.07
1.1
1.1
—
—
—
0
0
649
6356
2.26
2.02
25.4
19.3
90.97
90.51
fl
2.07
643
6308
23
126
1.86
2.00
1.9
1.2
—
—
—
0
0
649
6358
2.25
1.98
25.5
19.3
4.50
4.53
e12/l
0.84
642
6250
649
6358
2.25
1.98
25.7
19.6
40.47
40.64
%
0.37
643
6306
107
833
1.34
1.98
3.4
3.3
0.81
0.82
mmol/l
0.45
98
798
7
21
3.36
1.97
2.6
2.1
77.86
141.64
ng/l
—
7
21
126
1006
1.31
1.96
1.5
1.7
441.04
47066023.71
pmol/l
1.54
102
869
5
11
4.57
1.94
1.2
1.1
—
—
—
0
0
205
2380
0.80
1.92
2.4
3.3
0.00
0.03
estimate
1.95
23
536
43
284
1.55
1.92
1.7
1.9
3.08
3.70
mg/l
0.39
34
204
0
52
0.00
1.88
0.0
1.4
—
1965.19
—
0
7
649
6363
2.20
1.88
25.6
19.4
135.87
136.05
g/l
0.14
643
6312
160
1331
1.27
1.81
1.9
1.6
0.62
1.02
mg/l
3.36
102
1011
648
6355
2.08
1.79
25.6
19.4
266.32
256.37
e9/l
3.66
641
6258
18
95
1.92
1.77
1.7
1.7
—
—
—
0
0
29
178
1.66
1.76
1.9
1.9
1.61
1.37
g/l
0.60
23
158
6
18
3.35
1.75
1.3
1.1
—
—
—
0
0
33
210
1.60
1.74
1.4
1.3
—
—
—
0
0
5
13
3.87
1.72
1.4
1.2
—
—
—
0
0
5
13
3.87
1.72
1.4
1.3
—
—
—
0
0
5
13
3.87
1.72
1.2
1.4
—
—
—
0
0
49
343
1.46
1.70
1.3
1.4
201.60
241.01
miu/ml
0.27
24
174
28
173
1.65
1.66
1.2
1.1
3.45
4.30
—
6
36
6
146
0.41
1.66
1.3
1.5
—
—
—
0
0
10
42
2.40
1.62
1.1
1.0
—
—
—
0
0
17
91
1.89
1.62
1.4
1.1
—
—
—
0
0
38
256
1.51
1.59
1.9
2.4
42.18
41.24
u/l
0.10
33
234
6
20
3.02
1.58
1.0
1.0
0.34
0.32
u/ml
—
6
20
91
717
1.31
1.57
2.3
2.5
25.31
24.18
%
0.27
84
661
15
78
1.94
1.55
1.4
1.2
—
—
—
0
0
6
21
2.87
1.51
1.0
1.5
—
—
—
0
0
48
346
1.42
1.45
2.6
3.1
67.80
67.30
g/l
0.15
43
327
6
22
2.74
1.43
1.0
1.0
—
—
—
0
0
42
297
1.44
1.41
1.5
1.5
—
—
—
0
0
60
783
0.74
1.40
2.6
2.1
—
—
—
0
0
35
500
0.68
1.40
2.0
2.1
34.04
35.98
u/l
0.12
28
421
14
247
0.56
1.37
3.1
2.3
0.69
0.61
%
0.40
14
247
74
932
0.77
1.35
1.9
2.7
2.42
2.43
mmol/l
0.32
63
844
8
34
2.37
1.29
1.5
1.2
—
—
—
0
0
76
944
0.78
1.25
3.7
3.3
468.85
505.46
ng/l
0.03
43
622
15
252
0.59
1.24
3.1
2.3
1.56
1.31
%
0.43
15
252
13
70
1.87
1.24
2.2
2.0
—
—
—
0
0
49
646
0.74
1.24
2.5
2.0
—
—
—
0
0
12
63
1.92
1.23
1.1
1.1
—
—
—
0
0
29
197
1.49
1.21
2.6
1.6
31.45
40.47
nmol/l
2.35
29
188
8
38
2.12
1.18
1.3
1.7
—
—
—
0
0
11
57
1.95
1.17
1.0
1.3
—
—
—
0
0
15
247
0.60
1.16
2.8
2.8
1.02
1.02
ratio
0.21
15
230
0
34
0.00
1.16
0.0
1.6
—
—
—
0
0
5
20
2.51
1.15
5.0
2.0
—
—
—
0
0
10
51
1.98
1.11
1.1
1.1
—
—
—
0
0
16
96
1.68
1.11
1.1
1.1
1.00
1.66
—
5
20
12
67
1.81
1.05
1.1
1.1
—
—
—
0
0
77
629
1.25
1.05
6.6
5.5
1.03
1.04
mmol/l
0.17
65
580
8
151
0.52
1.04
1.3
1.4
0.18
0.36
nmol/l
—
8
124
9
158
0.56
0.99
1.0
1.2
—
—
—
0
0
9
159
0.56
0.99
1.0
1.2
—
—
—
0
0
9
49
1.85
0.99
4.1
2.2
—
—
—
0
0
57
453
1.28
0.98
3.4
4.4
153.68
29.07
ug/l
0.38
46
371
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
29
2.08
0.89
1.7
1.2
—
—
—
0
0
10
168
0.59
0.87
1.4
1.3
—
—
—
0
0
12
191
0.62
0.85
2.2
3.5
41.17
1628.81
u/ml
1.23
12
165
6
32
1.88
0.82
1.2
1.0
110.52
34.99
u/ml
—
6
32
66
548
1.23
0.81
1.3
1.3
143.30
147.49
u/ml
0.02
21
213
25
181
1.40
0.81
1.8
2.1
2.76
4.25
iu/l
—
9
81
10
58
1.74
0.80
1.2
1.1
—
—
—
0
0
0
28
0.00
0.76
0.0
1.2
—
70.89
—
0
28
57
682
0.82
0.72
3.2
3.0
0.79
0.75
ug/l
0.17
35
403
7
41
1.71
0.70
1.1
1.2
67.86
76.68
umol/l
—
7
41
9
58
1.56
0.70
1.4
1.6
21.56
22.24
nmol/l
—
9
51
19
136
1.41
0.67
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
104
1.45
0.63
1.9
3.2
0.40
0.37
iu/ml
—
6
55
8
51
1.58
0.60
1.8
1.5
1.25
1.15
promille
—
8
40
222
2373
0.90
0.60
2.0
1.9
1.49
1.34
mmol/l
1.85
186
2041
21
276
0.75
0.59
1.3
1.5
—
—
—
0
0
8
54
1.49
0.57
1.0
1.1
—
—
—
0
0
193
1792
1.11
0.57
2.3
3.2
2.35
2.35
mmol/l
0.02
157
1648
126
1144
1.13
0.55
4.4
4.8
1.53
2.12
ug/l
1.14
109
1033
300
3148
0.91
0.54
2.9
3.5
0.00
0.00
estimate
0.50
30
620
295
3094
0.92
0.52
2.8
3.4
0.00
0.00
estimate
0.50
33
648
17
126
1.36
0.52
1.9
1.7
—
—
—
0
0
167
1798
0.90
0.51
2.2
2.9
0.00
0.01
estimate
1.47
24
530
11
75
1.47
0.51
1.3
1.5
0.52
0.55
nmol/l
0.10
11
69
7
108
0.64
0.49
3.3
1.9
13.29
13.17
%
—
7
108
7
109
0.64
0.49
1.9
1.9
—
—
—
0
0
31
376
0.82
0.48
1.4
1.4
—
—
—
0
0
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
49
566
0.85
0.46
1.9
1.8
—
—
—
0
0
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
52
596
0.86
0.45
2.7
2.8
14.22
7.04
umol/l
0.77
46
511
5
31
1.62
0.43
1.8
1.2
172.56
173.71
pmol/l
—
5
31
300
3121
0.93
0.41
2.8
3.4
0.00
4.64
estimate
0.80
32
654
12
88
1.37
0.40
1.2
1.5
—
—
—
0
0
35
410
0.85
0.40
5.9
7.6
126.46
122.23
g/l
0.67
35
399
37
316
1.18
0.40
1.3
1.8
0.36
0.33
mg/l
0.13
21
141
0
19
0.00
0.39
0.0
3.2
—
1.63
—
0
19
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
8
113
0.70
0.37
1.3
1.2
—
—
—
0
0
36
417
0.86
0.37
1.6
1.4
—
—
—
0
0
30
351
0.85
0.35
2.6
2.7
22.47
83.68
u/ml
1.05
30
335
39
442
0.87
0.31
6.9
3.3
2.03
1.81
mmol/l
0.18
34
379
7
98
0.71
0.31
3.0
2.8
8.40
8.18
pmol/l
—
7
98
29
251
1.16
0.29
1.5
1.4
—
—
—
0
0
14
112
1.26
0.28
1.1
1.5
—
—
—
0
0
84
904
0.92
0.28
3.5
4.0
24.99
21.97
%
0.84
34
389
8
67
1.20
0.26
1.4
1.4
—
—
—
0
0
17
141
1.21
0.26
1.2
1.1
7.22
12.29
au/ml
—
8
51
59
643
0.91
0.26
1.7
1.7
3.33
3.48
mmol/l
0.44
42
459
9
72
1.25
0.25
1.2
1.6
—
—
—
0
0
14
114
1.23
0.25
1.1
1.6
—
—
—
0
0
16
133
1.21
0.24
2.2
1.7
—
—
—
0
0
195
2022
0.95
0.23
3.2
3.3
31.10
30.42
u/l
0.14
184
1911
79
739
1.08
0.23
2.2
2.0
28.98
29.09
s
0.05
74
720
0
10
0.00
0.21
0.0
1.1
—
1.35
—
0
10
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
18
155
1.17
0.20
1.2
1.2
—
44.84
—
0
5
164
1701
0.95
0.20
2.5
3.5
0.00
0.01
estimate
1.15
29
626
15
127
1.19
0.19
4.5
3.7
1.35
3.01
ratio
—
10
78
6
51
1.18
0.19
2.0
1.5
—
—
—
0
0
13
109
1.20
0.18
1.8
2.3
103.90
104.92
ug/min
—
7
66
88
836
1.06
0.18
1.7
1.9
3.57
3.45
ratio
0.31
69
649
21
236
0.89
0.17
6.8
8.9
15.61
15.95
%
0.23
21
225
5
68
0.73
0.17
1.8
2.3
—
—
—
0
0
11
93
1.19
0.14
1.0
1.4
—
—
—
0
0
7
90
0.78
0.14
1.7
1.4
—
—
—
0
0
25
274
0.91
0.14
1.7
1.9
—
—
—
0
0
9
108
0.83
0.13
1.1
1.1
—
—
—
0
0
46
487
0.94
0.12
5.2
7.0
0.05
0.60
mmol/l
0.21
33
397
41
389
1.06
0.09
2.1
2.6
77.40
73.37
ml/min/173m2
0.27
15
159
10
87
1.15
0.09
1.3
1.1
—
1.17
—
0
6
12
107
1.12
0.08
1.2
1.3
4.00
6.51
u/ml
—
6
43
31
321
0.96
0.03
1.3
1.7
305.00
304.47
mu/l
0.00
31
288
33
322
1.03
0.02
1.2
1.4
—
—
—
0
0
36
356
1.01
0.00
1.4
1.5
55.20
60.81
ug/l
0.48
36
298
10
101
0.99
0.00
1.2
1.5
—
—
—
0
0
33
329
1.00
0.00
1.3
1.4
1.02
0.98
ratio
0.29
28
203
33
329
1.00
0.00
1.3
1.4
1.24
1.17
ratio
0.30
28
203
33
329
1.00
0.00
1.3
1.4
1.07
1.10
ratio
0.11
28
203
6
62
0.97
0.00
5.8
5.1
13.95
11.15
mg/l
—
6
57
0
7
0.00
-0.00
0.0
8.7
—
6.00
—
0
7
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
53
0.94
-0.00
2.4
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
9.8
—
11.28
—
0
6
0
6
0.00
-0.00
0.0
2.7
—
0.50
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
78
0.90
-0.00
1.1
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.2
—
7.77
—
0
6
7
73
0.96
-0.00
1.3
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_DYSHIDROSIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_DYSHIDROSIS | 1.254 [0.92, 1.71] | 0.15 |
| Birth year | 0.999 [0.99, 1.01] | 0.788 |
During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 1569 females with L12_DYSHIDROSIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_DYSHIDROSIS | 1.603 [1.25, 2.06] | < 0.001 |
| Birth year | 0.985 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 93 out of 941 males with L12_DYSHIDROSIS died.
Mortality risk
Mortality risk for people of age
years, who have L12_DYSHIDROSIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.106% | 0.215% |
| 5 | 0.884% | 1.593% |
| 10 | 2.169% | 4.084% |
| 15 | 3.959% | 7.696% |
| 20 | 7.136% | 13.227% |
Relationships between endpoints
↥Index endpoint: L12_DYSHIDROSIS – Dyshidrosis [pompholyx]
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data